Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy
Purpose Accurate identification of nodal status enables adequate neck irradiation for nasopharyngeal carcinoma (NPC). However, most conventional techniques are unable to pick up occult metastases, leading to underestimation of tumor extensions. Here we investigate the clinical significance of carbon...
Gespeichert in:
Veröffentlicht in: | European journal of nuclear medicine and molecular imaging 2022-11, Vol.49 (13), p.4427-4439 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4439 |
---|---|
container_issue | 13 |
container_start_page | 4427 |
container_title | European journal of nuclear medicine and molecular imaging |
container_volume | 49 |
creator | Huang, Wenhui Wang, Kun Huang, Weiyuan He, Zicong Zhang, Jingming Zhang, Bin Xiong, Zhiyuan Gillen, Kelly McCabe Li, Wenzhe Chen, Feng Yang, Xing Zhang, Shuixing Tian, Jie |
description | Purpose
Accurate identification of nodal status enables adequate neck irradiation for nasopharyngeal carcinoma (NPC). However, most conventional techniques are unable to pick up occult metastases, leading to underestimation of tumor extensions. Here we investigate the clinical significance of carbonic anhydrase IX (CAIX) in human NPC samples, and develop a CAIX-targeted imaging strategy to identify occult lymph node metastases (LNMs) and extranodal extension (ENE) in animal studies.
Methods
A total of 211 NPC samples are performed CAIX staining, and clinical outcomes are analyzed. The metastatic murine models are generated by foot pad injection of NPC cells, and a CAIX-targeted imaging agent (CAIX-800) is intravenously administered. We adopt fluorescence molecular tomography and ultrasonography (US)-guided spectroscopic photoacoustic (sPA) imaging to perform
in vivo
studies. Histological and immunohistochemical characterization are carried out via node-by-node analysis.
Results
For clinical samples, 90.1% (91/101) primary tumors, 73.3% (66/90) metastases, and 100% (20/20) local recurrences are CAIX positive. In metastases group, 84.7% (61/72) nodal metastases and 22.2% (4/18) organ metastases are CAIX positive. CAIX expression in primary tumors is significantly associated with NPC stage and prognosis. For animal studies, CAIX-800-based fluorescence imaging achieves 81.3% sensitivity and 93.8% specificity in detecting occult LNMs
in vivo
, with a minimum detectable diameter of 1.7 mm. Coupled with CAIX-800, US-guided sPA imaging could not only detect subcapsular deposits of metastatic cancer cells 2 weeks earlier than conventional techniques, but also successfully track pathological ENE.
Conclusion
CAIX remarkably expresses in human NPCs and stratifies patient prognosis. In preclinical studies, CAIX-800-based imaging successfully identifies occult LNMs and tracks early stage of pathological ENE. This attractive method shows potential in clinic, allowing medical workers to longitudinally monitor nodal status and helping to reduce unnecessary nodal biopsy for patients with NPC.
Graphical abstract
The schematic diagram for the study. CAIX, carbonic anhydrase IX; NPC, nasopharyngeal carcinoma; US, ultrasonography; sPA, spectroscopic photoacoustic. |
doi_str_mv | 10.1007/s00259-022-05922-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2698632416</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2728738004</sourcerecordid><originalsourceid>FETCH-LOGICAL-c352t-40096dc9c99144584de7168155507a96cde6fa87caad7551e31a7f95164a7d4b3</originalsourceid><addsrcrecordid>eNp9kc1q3TAQhU1JoUnaF-hK0E03biTZ-luGS5MGAt200J2YSLKjYEu3GntxHybvGt04tJBFNtIw880ZjU7TfGb0G6NUXSClXJiWct5SYeop3zWnTDLTKqrNyb9Y0Q_NGeIDpUxzbU6bxx2Uu5yiI5DuD74ABnLzh-BSYIlDDEj2NQhpIfuSx5QxYiU9ib7mNiBlD1PtgGVFElMtx7km5uzDhCQPJAHm_T2UQxpDLTgoLqY8A1kxppEAWaCMYQlVdYbxmHoeH8bDx-b9ABOGTy_3efP76vuv3Y_29uf1ze7ytnWd4EvbU2qkd8YZw_pe6N4HxaRmQgiqwEjngxxAKwfglRAsdAzUYASTPSjf33XnzddNty75dw242DmiC9MEKeQVLZdGy473TFb0yyv0Ia8l1ddZrrhWnaa0rxTfKFcyYgmD3Ze6XDlYRu3RMbs5Zqtj9tkxe5TutiascP2r8l_6ja4nyy6cAg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2728738004</pqid></control><display><type>article</type><title>Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy</title><source>SpringerLink Journals - AutoHoldings</source><creator>Huang, Wenhui ; Wang, Kun ; Huang, Weiyuan ; He, Zicong ; Zhang, Jingming ; Zhang, Bin ; Xiong, Zhiyuan ; Gillen, Kelly McCabe ; Li, Wenzhe ; Chen, Feng ; Yang, Xing ; Zhang, Shuixing ; Tian, Jie</creator><creatorcontrib>Huang, Wenhui ; Wang, Kun ; Huang, Weiyuan ; He, Zicong ; Zhang, Jingming ; Zhang, Bin ; Xiong, Zhiyuan ; Gillen, Kelly McCabe ; Li, Wenzhe ; Chen, Feng ; Yang, Xing ; Zhang, Shuixing ; Tian, Jie</creatorcontrib><description>Purpose
Accurate identification of nodal status enables adequate neck irradiation for nasopharyngeal carcinoma (NPC). However, most conventional techniques are unable to pick up occult metastases, leading to underestimation of tumor extensions. Here we investigate the clinical significance of carbonic anhydrase IX (CAIX) in human NPC samples, and develop a CAIX-targeted imaging strategy to identify occult lymph node metastases (LNMs) and extranodal extension (ENE) in animal studies.
Methods
A total of 211 NPC samples are performed CAIX staining, and clinical outcomes are analyzed. The metastatic murine models are generated by foot pad injection of NPC cells, and a CAIX-targeted imaging agent (CAIX-800) is intravenously administered. We adopt fluorescence molecular tomography and ultrasonography (US)-guided spectroscopic photoacoustic (sPA) imaging to perform
in vivo
studies. Histological and immunohistochemical characterization are carried out via node-by-node analysis.
Results
For clinical samples, 90.1% (91/101) primary tumors, 73.3% (66/90) metastases, and 100% (20/20) local recurrences are CAIX positive. In metastases group, 84.7% (61/72) nodal metastases and 22.2% (4/18) organ metastases are CAIX positive. CAIX expression in primary tumors is significantly associated with NPC stage and prognosis. For animal studies, CAIX-800-based fluorescence imaging achieves 81.3% sensitivity and 93.8% specificity in detecting occult LNMs
in vivo
, with a minimum detectable diameter of 1.7 mm. Coupled with CAIX-800, US-guided sPA imaging could not only detect subcapsular deposits of metastatic cancer cells 2 weeks earlier than conventional techniques, but also successfully track pathological ENE.
Conclusion
CAIX remarkably expresses in human NPCs and stratifies patient prognosis. In preclinical studies, CAIX-800-based imaging successfully identifies occult LNMs and tracks early stage of pathological ENE. This attractive method shows potential in clinic, allowing medical workers to longitudinally monitor nodal status and helping to reduce unnecessary nodal biopsy for patients with NPC.
Graphical abstract
The schematic diagram for the study. CAIX, carbonic anhydrase IX; NPC, nasopharyngeal carcinoma; US, ultrasonography; sPA, spectroscopic photoacoustic.</description><identifier>ISSN: 1619-7070</identifier><identifier>EISSN: 1619-7089</identifier><identifier>DOI: 10.1007/s00259-022-05922-6</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Animal models ; Biopsy ; Cancer ; Carbonic anhydrase ; Carbonic anhydrases ; Cardiology ; Fluorescence ; Imaging ; In vivo methods and tests ; Lymph nodes ; Medical imaging ; Medical personnel ; Medical prognosis ; Medicine ; Medicine & Public Health ; Metastases ; Metastasis ; Nasopharyngeal carcinoma ; Nuclear Medicine ; Oncology ; Oncology – Head and Neck ; Original Article ; Orthopedics ; Patients ; Prognosis ; Radiation ; Radiology ; Throat cancer ; Tracks (paths) ; Tumors ; Ultrasonic imaging</subject><ispartof>European journal of nuclear medicine and molecular imaging, 2022-11, Vol.49 (13), p.4427-4439</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c352t-40096dc9c99144584de7168155507a96cde6fa87caad7551e31a7f95164a7d4b3</citedby><cites>FETCH-LOGICAL-c352t-40096dc9c99144584de7168155507a96cde6fa87caad7551e31a7f95164a7d4b3</cites><orcidid>0000-0003-0498-0432</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00259-022-05922-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00259-022-05922-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Huang, Wenhui</creatorcontrib><creatorcontrib>Wang, Kun</creatorcontrib><creatorcontrib>Huang, Weiyuan</creatorcontrib><creatorcontrib>He, Zicong</creatorcontrib><creatorcontrib>Zhang, Jingming</creatorcontrib><creatorcontrib>Zhang, Bin</creatorcontrib><creatorcontrib>Xiong, Zhiyuan</creatorcontrib><creatorcontrib>Gillen, Kelly McCabe</creatorcontrib><creatorcontrib>Li, Wenzhe</creatorcontrib><creatorcontrib>Chen, Feng</creatorcontrib><creatorcontrib>Yang, Xing</creatorcontrib><creatorcontrib>Zhang, Shuixing</creatorcontrib><creatorcontrib>Tian, Jie</creatorcontrib><title>Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy</title><title>European journal of nuclear medicine and molecular imaging</title><addtitle>Eur J Nucl Med Mol Imaging</addtitle><description>Purpose
Accurate identification of nodal status enables adequate neck irradiation for nasopharyngeal carcinoma (NPC). However, most conventional techniques are unable to pick up occult metastases, leading to underestimation of tumor extensions. Here we investigate the clinical significance of carbonic anhydrase IX (CAIX) in human NPC samples, and develop a CAIX-targeted imaging strategy to identify occult lymph node metastases (LNMs) and extranodal extension (ENE) in animal studies.
Methods
A total of 211 NPC samples are performed CAIX staining, and clinical outcomes are analyzed. The metastatic murine models are generated by foot pad injection of NPC cells, and a CAIX-targeted imaging agent (CAIX-800) is intravenously administered. We adopt fluorescence molecular tomography and ultrasonography (US)-guided spectroscopic photoacoustic (sPA) imaging to perform
in vivo
studies. Histological and immunohistochemical characterization are carried out via node-by-node analysis.
Results
For clinical samples, 90.1% (91/101) primary tumors, 73.3% (66/90) metastases, and 100% (20/20) local recurrences are CAIX positive. In metastases group, 84.7% (61/72) nodal metastases and 22.2% (4/18) organ metastases are CAIX positive. CAIX expression in primary tumors is significantly associated with NPC stage and prognosis. For animal studies, CAIX-800-based fluorescence imaging achieves 81.3% sensitivity and 93.8% specificity in detecting occult LNMs
in vivo
, with a minimum detectable diameter of 1.7 mm. Coupled with CAIX-800, US-guided sPA imaging could not only detect subcapsular deposits of metastatic cancer cells 2 weeks earlier than conventional techniques, but also successfully track pathological ENE.
Conclusion
CAIX remarkably expresses in human NPCs and stratifies patient prognosis. In preclinical studies, CAIX-800-based imaging successfully identifies occult LNMs and tracks early stage of pathological ENE. This attractive method shows potential in clinic, allowing medical workers to longitudinally monitor nodal status and helping to reduce unnecessary nodal biopsy for patients with NPC.
Graphical abstract
The schematic diagram for the study. CAIX, carbonic anhydrase IX; NPC, nasopharyngeal carcinoma; US, ultrasonography; sPA, spectroscopic photoacoustic.</description><subject>Animal models</subject><subject>Biopsy</subject><subject>Cancer</subject><subject>Carbonic anhydrase</subject><subject>Carbonic anhydrases</subject><subject>Cardiology</subject><subject>Fluorescence</subject><subject>Imaging</subject><subject>In vivo methods and tests</subject><subject>Lymph nodes</subject><subject>Medical imaging</subject><subject>Medical personnel</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Nasopharyngeal carcinoma</subject><subject>Nuclear Medicine</subject><subject>Oncology</subject><subject>Oncology – Head and Neck</subject><subject>Original Article</subject><subject>Orthopedics</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Radiation</subject><subject>Radiology</subject><subject>Throat cancer</subject><subject>Tracks (paths)</subject><subject>Tumors</subject><subject>Ultrasonic imaging</subject><issn>1619-7070</issn><issn>1619-7089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9kc1q3TAQhU1JoUnaF-hK0E03biTZ-luGS5MGAt200J2YSLKjYEu3GntxHybvGt04tJBFNtIw880ZjU7TfGb0G6NUXSClXJiWct5SYeop3zWnTDLTKqrNyb9Y0Q_NGeIDpUxzbU6bxx2Uu5yiI5DuD74ABnLzh-BSYIlDDEj2NQhpIfuSx5QxYiU9ib7mNiBlD1PtgGVFElMtx7km5uzDhCQPJAHm_T2UQxpDLTgoLqY8A1kxppEAWaCMYQlVdYbxmHoeH8bDx-b9ABOGTy_3efP76vuv3Y_29uf1ze7ytnWd4EvbU2qkd8YZw_pe6N4HxaRmQgiqwEjngxxAKwfglRAsdAzUYASTPSjf33XnzddNty75dw242DmiC9MEKeQVLZdGy473TFb0yyv0Ia8l1ddZrrhWnaa0rxTfKFcyYgmD3Ze6XDlYRu3RMbs5Zqtj9tkxe5TutiascP2r8l_6ja4nyy6cAg</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>Huang, Wenhui</creator><creator>Wang, Kun</creator><creator>Huang, Weiyuan</creator><creator>He, Zicong</creator><creator>Zhang, Jingming</creator><creator>Zhang, Bin</creator><creator>Xiong, Zhiyuan</creator><creator>Gillen, Kelly McCabe</creator><creator>Li, Wenzhe</creator><creator>Chen, Feng</creator><creator>Yang, Xing</creator><creator>Zhang, Shuixing</creator><creator>Tian, Jie</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0498-0432</orcidid></search><sort><creationdate>20221101</creationdate><title>Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy</title><author>Huang, Wenhui ; Wang, Kun ; Huang, Weiyuan ; He, Zicong ; Zhang, Jingming ; Zhang, Bin ; Xiong, Zhiyuan ; Gillen, Kelly McCabe ; Li, Wenzhe ; Chen, Feng ; Yang, Xing ; Zhang, Shuixing ; Tian, Jie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c352t-40096dc9c99144584de7168155507a96cde6fa87caad7551e31a7f95164a7d4b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animal models</topic><topic>Biopsy</topic><topic>Cancer</topic><topic>Carbonic anhydrase</topic><topic>Carbonic anhydrases</topic><topic>Cardiology</topic><topic>Fluorescence</topic><topic>Imaging</topic><topic>In vivo methods and tests</topic><topic>Lymph nodes</topic><topic>Medical imaging</topic><topic>Medical personnel</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Nasopharyngeal carcinoma</topic><topic>Nuclear Medicine</topic><topic>Oncology</topic><topic>Oncology – Head and Neck</topic><topic>Original Article</topic><topic>Orthopedics</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Radiation</topic><topic>Radiology</topic><topic>Throat cancer</topic><topic>Tracks (paths)</topic><topic>Tumors</topic><topic>Ultrasonic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Wenhui</creatorcontrib><creatorcontrib>Wang, Kun</creatorcontrib><creatorcontrib>Huang, Weiyuan</creatorcontrib><creatorcontrib>He, Zicong</creatorcontrib><creatorcontrib>Zhang, Jingming</creatorcontrib><creatorcontrib>Zhang, Bin</creatorcontrib><creatorcontrib>Xiong, Zhiyuan</creatorcontrib><creatorcontrib>Gillen, Kelly McCabe</creatorcontrib><creatorcontrib>Li, Wenzhe</creatorcontrib><creatorcontrib>Chen, Feng</creatorcontrib><creatorcontrib>Yang, Xing</creatorcontrib><creatorcontrib>Zhang, Shuixing</creatorcontrib><creatorcontrib>Tian, Jie</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of nuclear medicine and molecular imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Wenhui</au><au>Wang, Kun</au><au>Huang, Weiyuan</au><au>He, Zicong</au><au>Zhang, Jingming</au><au>Zhang, Bin</au><au>Xiong, Zhiyuan</au><au>Gillen, Kelly McCabe</au><au>Li, Wenzhe</au><au>Chen, Feng</au><au>Yang, Xing</au><au>Zhang, Shuixing</au><au>Tian, Jie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy</atitle><jtitle>European journal of nuclear medicine and molecular imaging</jtitle><stitle>Eur J Nucl Med Mol Imaging</stitle><date>2022-11-01</date><risdate>2022</risdate><volume>49</volume><issue>13</issue><spage>4427</spage><epage>4439</epage><pages>4427-4439</pages><issn>1619-7070</issn><eissn>1619-7089</eissn><abstract>Purpose
Accurate identification of nodal status enables adequate neck irradiation for nasopharyngeal carcinoma (NPC). However, most conventional techniques are unable to pick up occult metastases, leading to underestimation of tumor extensions. Here we investigate the clinical significance of carbonic anhydrase IX (CAIX) in human NPC samples, and develop a CAIX-targeted imaging strategy to identify occult lymph node metastases (LNMs) and extranodal extension (ENE) in animal studies.
Methods
A total of 211 NPC samples are performed CAIX staining, and clinical outcomes are analyzed. The metastatic murine models are generated by foot pad injection of NPC cells, and a CAIX-targeted imaging agent (CAIX-800) is intravenously administered. We adopt fluorescence molecular tomography and ultrasonography (US)-guided spectroscopic photoacoustic (sPA) imaging to perform
in vivo
studies. Histological and immunohistochemical characterization are carried out via node-by-node analysis.
Results
For clinical samples, 90.1% (91/101) primary tumors, 73.3% (66/90) metastases, and 100% (20/20) local recurrences are CAIX positive. In metastases group, 84.7% (61/72) nodal metastases and 22.2% (4/18) organ metastases are CAIX positive. CAIX expression in primary tumors is significantly associated with NPC stage and prognosis. For animal studies, CAIX-800-based fluorescence imaging achieves 81.3% sensitivity and 93.8% specificity in detecting occult LNMs
in vivo
, with a minimum detectable diameter of 1.7 mm. Coupled with CAIX-800, US-guided sPA imaging could not only detect subcapsular deposits of metastatic cancer cells 2 weeks earlier than conventional techniques, but also successfully track pathological ENE.
Conclusion
CAIX remarkably expresses in human NPCs and stratifies patient prognosis. In preclinical studies, CAIX-800-based imaging successfully identifies occult LNMs and tracks early stage of pathological ENE. This attractive method shows potential in clinic, allowing medical workers to longitudinally monitor nodal status and helping to reduce unnecessary nodal biopsy for patients with NPC.
Graphical abstract
The schematic diagram for the study. CAIX, carbonic anhydrase IX; NPC, nasopharyngeal carcinoma; US, ultrasonography; sPA, spectroscopic photoacoustic.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><doi>10.1007/s00259-022-05922-6</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-0498-0432</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1619-7070 |
ispartof | European journal of nuclear medicine and molecular imaging, 2022-11, Vol.49 (13), p.4427-4439 |
issn | 1619-7070 1619-7089 |
language | eng |
recordid | cdi_proquest_miscellaneous_2698632416 |
source | SpringerLink Journals - AutoHoldings |
subjects | Animal models Biopsy Cancer Carbonic anhydrase Carbonic anhydrases Cardiology Fluorescence Imaging In vivo methods and tests Lymph nodes Medical imaging Medical personnel Medical prognosis Medicine Medicine & Public Health Metastases Metastasis Nasopharyngeal carcinoma Nuclear Medicine Oncology Oncology – Head and Neck Original Article Orthopedics Patients Prognosis Radiation Radiology Throat cancer Tracks (paths) Tumors Ultrasonic imaging |
title | Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T23%3A57%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carbonic%20anhydrase%20IX%20stratifies%20patient%20prognosis%20and%20identifies%20nodal%20status%20in%20animal%20models%20of%20nasopharyngeal%20carcinoma%20using%20a%20targeted%20imaging%20strategy&rft.jtitle=European%20journal%20of%20nuclear%20medicine%20and%20molecular%20imaging&rft.au=Huang,%20Wenhui&rft.date=2022-11-01&rft.volume=49&rft.issue=13&rft.spage=4427&rft.epage=4439&rft.pages=4427-4439&rft.issn=1619-7070&rft.eissn=1619-7089&rft_id=info:doi/10.1007/s00259-022-05922-6&rft_dat=%3Cproquest_cross%3E2728738004%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2728738004&rft_id=info:pmid/&rfr_iscdi=true |